Hong‐Mei An
- Molecular Biology
- Cancer Research
- Complementary and alternative medicine top 5%
- Pharmacology top 10%
- Plant Science
- Topics
- Cancer-related Molecular Pathways (6 papers)Natural product bioactivities and synthesis (5 papers)Alzheimer's disease research and treatments (5 papers)
- Partner nations
- ChinaBangladeshGermany
In The Last Decade
Hong‐Mei An
42 papers receiving 686 citations
Peers
Comparison fields: 5 of 90
- Molecular Biology 409
- Cancer Research 116
- Complementary and alternative medicine 99
- Pharmacology 95
- Plant Science 88
Countries citing papers authored by Hong‐Mei An
This map shows the geographic impact of Hong‐Mei An's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hong‐Mei An with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hong‐Mei An more than expected).
Fields of papers citing papers by Hong‐Mei An
This network shows the impact of papers produced by Hong‐Mei An. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hong‐Mei An. The network helps show where Hong‐Mei An may publish in the future.
Co-authorship network of co-authors of Hong‐Mei An
This figure shows the co-authorship network connecting the top 25 collaborators of Hong‐Mei An. A scholar is included among the top collaborators of Hong‐Mei An based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hong‐Mei An. Hong‐Mei An is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 1 | |
| 3 | 1 | |
| 4 | 4 | |
| 5 | 2 | |
| 6 | 2 | |
| 7 | 17 | |
| 8 | 22 | |
| 9 | 14 | |
| 10 | 11 | |
| 11 | 13 | |
| 12 | 21 | |
| 13 | Teng-Long-Bu-Zhong-Tang decoction promotes cell senescence of human colon carcinoma RKO cells and its possible mechanism | 2 |
| 14 | 46 | |
| 15 | Analysis on the Consumption Structure of Rural Household Energy in Jilin Province | 1 |
| 16 | 37 | |
| 17 | 25 | |
| 18 | 10 | |
| 19 | Low dose of etoposide induces cell senescence in colon carcinoma. | 1 |
| 20 | [Epigenetic inactivation of the WNT antagonist SFRP1 in breast cancer]. | 7 |
About Hong‐Mei An
Hong‐Mei An is a scholar working on Complementary and alternative medicine, Biological Psychiatry and Cancer Research, having authored 43 papers that have together received 707 indexed citations. Recurring topics across this work include Cancer-related Molecular Pathways (6 papers), Natural product bioactivities and synthesis (5 papers) and Alzheimer's disease research and treatments (5 papers). The work is most often cited by research in Molecular Medicine (67 citations), Complementary and alternative medicine (99 citations) and Pharmacology (69 citations). Hong‐Mei An has collaborated with scholars based in China, Bangladesh and Germany. Frequent co-authors include Bing Hu, Ke‐Ping Shen, Shan Deng, Bing Hu, Mengmeng Wei, Ling Xu, Shuangshuang Wang, Qin Du, Jinjun Chen and Yang Wu. Their work appears in journals such as Food Chemistry, Molecules and Journal of Alzheimer s Disease.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.